AmWeb: A novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients

Dean Ironmonger; Obaghe Edeghere; Savita Gossain; Amardeep Bains; Peter M. Hawkey

doi:10.1093/jac/dkt181

AmWeb: A novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients

Dean Ironmonger^*, Obaghe Edeghere, Savita Gossain, Amardeep Bains, Peter M. Hawkey

^*Corresponding author for this work

Field Service Divisional Office

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

Background:Antimicrobial resistance (AMR) is recognized as one of the most significant threats to human health. Local and regionalAMRsurveillance enables the monitoring of temporal changes in susceptibility to antibiotics and can provide prescribing guidance to healthcare providers to improve patient management and help slow the spread of antibiotic resistance in the community. There is currently a paucity of routine community-level AMR surveillance information. Methods:The HPA in England sponsored the development of an AMR surveillance system (AmSurv) to collate local laboratory reports. In theWest Midlands region of England, routine reporting of AMR data has been established via the AmSurv systemfromall diagnostic microbiology laboratories. TheHPARegional Epidemiology Unit developed a web-enabled database application (AmWeb) to provide microbiologists, pharmacists and other stakeholders with timely access to AMR data using user-configurable reporting tools.Results: AmWebwas launched in theWest Midlands in January 2012 and is used by microbiologists and pharmacists to monitor resistance profiles, perform local benchmarking and compile data for infection control reports. AmWeb is now being rolled out to all English regions. Conclusions:It is expected thatAmWebwillbecomeavaluable tool for monitoring the threat fromnewlyemerging or currently circulating resistant organisms and helping antibiotic prescribers to select the best treatment options for their patients.

Original language	English
Article number	dkt181
Pages (from-to)	2406-2413
Number of pages	8
Journal	Journal of Antimicrobial Chemotherapy
Volume	68
Issue number	10
DOIs	https://doi.org/10.1093/jac/dkt181
Publication status	Published - Oct 2013

Bibliographical note

Funding Information:
P. M. H. has received honoraria for developing and delivering educational presentations for Eumedica, Pfizer, Merck, Novartis, Magus Communications and Wyeth and received research funding from Pfizer, Eumedica; consultancy for Pfizer, Novartis, Basilea, Novacta, Novolytics, Merck, Wyeth and Optimer. He is a director of ModusMedica, a medical education company. All other authors: none to declare.

Funding Information:
This work was supported by the HPA.

Keywords

Antibiotics
Health informatics
Microbiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jac/dkt181

Cite this

@article{88995035b8f6440aaf2d5aa08ee82c48,

title = "AmWeb: A novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients",

abstract = "Background:Antimicrobial resistance (AMR) is recognized as one of the most significant threats to human health. Local and regionalAMRsurveillance enables the monitoring of temporal changes in susceptibility to antibiotics and can provide prescribing guidance to healthcare providers to improve patient management and help slow the spread of antibiotic resistance in the community. There is currently a paucity of routine community-level AMR surveillance information. Methods:The HPA in England sponsored the development of an AMR surveillance system (AmSurv) to collate local laboratory reports. In theWest Midlands region of England, routine reporting of AMR data has been established via the AmSurv systemfromall diagnostic microbiology laboratories. TheHPARegional Epidemiology Unit developed a web-enabled database application (AmWeb) to provide microbiologists, pharmacists and other stakeholders with timely access to AMR data using user-configurable reporting tools.Results: AmWebwas launched in theWest Midlands in January 2012 and is used by microbiologists and pharmacists to monitor resistance profiles, perform local benchmarking and compile data for infection control reports. AmWeb is now being rolled out to all English regions. Conclusions:It is expected thatAmWebwillbecomeavaluable tool for monitoring the threat fromnewlyemerging or currently circulating resistant organisms and helping antibiotic prescribers to select the best treatment options for their patients.",

keywords = "Antibiotics, Health informatics, Microbiology",

author = "Dean Ironmonger and Obaghe Edeghere and Savita Gossain and Amardeep Bains and Hawkey, {Peter M.}",

note = "Funding Information: P. M. H. has received honoraria for developing and delivering educational presentations for Eumedica, Pfizer, Merck, Novartis, Magus Communications and Wyeth and received research funding from Pfizer, Eumedica; consultancy for Pfizer, Novartis, Basilea, Novacta, Novolytics, Merck, Wyeth and Optimer. He is a director of ModusMedica, a medical education company. All other authors: none to declare. Funding Information: This work was supported by the HPA.",

year = "2013",

month = oct,

doi = "10.1093/jac/dkt181",

language = "English",

volume = "68",

pages = "2406--2413",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - AmWeb

T2 - A novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients

AU - Ironmonger, Dean

AU - Edeghere, Obaghe

AU - Gossain, Savita

AU - Bains, Amardeep

AU - Hawkey, Peter M.

N1 - Funding Information: P. M. H. has received honoraria for developing and delivering educational presentations for Eumedica, Pfizer, Merck, Novartis, Magus Communications and Wyeth and received research funding from Pfizer, Eumedica; consultancy for Pfizer, Novartis, Basilea, Novacta, Novolytics, Merck, Wyeth and Optimer. He is a director of ModusMedica, a medical education company. All other authors: none to declare. Funding Information: This work was supported by the HPA.

PY - 2013/10

Y1 - 2013/10

N2 - Background:Antimicrobial resistance (AMR) is recognized as one of the most significant threats to human health. Local and regionalAMRsurveillance enables the monitoring of temporal changes in susceptibility to antibiotics and can provide prescribing guidance to healthcare providers to improve patient management and help slow the spread of antibiotic resistance in the community. There is currently a paucity of routine community-level AMR surveillance information. Methods:The HPA in England sponsored the development of an AMR surveillance system (AmSurv) to collate local laboratory reports. In theWest Midlands region of England, routine reporting of AMR data has been established via the AmSurv systemfromall diagnostic microbiology laboratories. TheHPARegional Epidemiology Unit developed a web-enabled database application (AmWeb) to provide microbiologists, pharmacists and other stakeholders with timely access to AMR data using user-configurable reporting tools.Results: AmWebwas launched in theWest Midlands in January 2012 and is used by microbiologists and pharmacists to monitor resistance profiles, perform local benchmarking and compile data for infection control reports. AmWeb is now being rolled out to all English regions. Conclusions:It is expected thatAmWebwillbecomeavaluable tool for monitoring the threat fromnewlyemerging or currently circulating resistant organisms and helping antibiotic prescribers to select the best treatment options for their patients.

AB - Background:Antimicrobial resistance (AMR) is recognized as one of the most significant threats to human health. Local and regionalAMRsurveillance enables the monitoring of temporal changes in susceptibility to antibiotics and can provide prescribing guidance to healthcare providers to improve patient management and help slow the spread of antibiotic resistance in the community. There is currently a paucity of routine community-level AMR surveillance information. Methods:The HPA in England sponsored the development of an AMR surveillance system (AmSurv) to collate local laboratory reports. In theWest Midlands region of England, routine reporting of AMR data has been established via the AmSurv systemfromall diagnostic microbiology laboratories. TheHPARegional Epidemiology Unit developed a web-enabled database application (AmWeb) to provide microbiologists, pharmacists and other stakeholders with timely access to AMR data using user-configurable reporting tools.Results: AmWebwas launched in theWest Midlands in January 2012 and is used by microbiologists and pharmacists to monitor resistance profiles, perform local benchmarking and compile data for infection control reports. AmWeb is now being rolled out to all English regions. Conclusions:It is expected thatAmWebwillbecomeavaluable tool for monitoring the threat fromnewlyemerging or currently circulating resistant organisms and helping antibiotic prescribers to select the best treatment options for their patients.

KW - Antibiotics

KW - Health informatics

KW - Microbiology

UR - http://www.scopus.com/inward/record.url?scp=84888786930&partnerID=8YFLogxK

U2 - 10.1093/jac/dkt181

DO - 10.1093/jac/dkt181

M3 - Article

C2 - 23687187

AN - SCOPUS:84888786930

SN - 0305-7453

VL - 68

SP - 2406

EP - 2413

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 10

M1 - dkt181

ER -

AmWeb: A novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this